Related references
Note: Only part of the references are listed.Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature
Hermann dos Santos Fernandes et al.
BMC ANESTHESIOLOGY (2019)
Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers
P. -J. de Kam et al.
BRITISH JOURNAL OF ANAESTHESIA (2018)
Current Status of Neuromuscular Reversal and Monitoring Challenges and Opportunities
Sorin J. Brull et al.
ANESTHESIOLOGY (2017)
The Impact of Residual Neuromuscular Blockade, Oversedation, and Hypothermia on Adverse Respiratory Events in a Postanesthetic Care Unit: A Prospective Study of Prevalence, Predictors, and Outcomes
Paul A. Stewart et al.
ANESTHESIA AND ANALGESIA (2016)
Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade A case report
Jose R. Ortiz-Gomez et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2014)
Residual neuromuscular block in type II diabetes mellitus after rocuronium A prospective observational study
Ignacio Armendariz-Buil et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2014)
Fade of train-of-four ratio despite administration of more than 12 mg kg-1 sugammadex in a myasthenia gravis patient receiving rocuronium
G. Kiss et al.
BRITISH JOURNAL OF ANAESTHESIA (2013)
Recurarization after sugammadex reversal in an obese patient
Frederique Le Corre et al.
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2011)
The Effect of Residual Neuromuscular Blockade on the Speed of Reversal with Sugammadex
Paul F. White et al.
ANESTHESIA AND ANALGESIA (2009)
Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study - Efficacy, safety, and pharmacokinetics
Harald J. Sparr et al.
ANESTHESIOLOGY (2007)
Onset and duration of action of rocuronium - from tracheal intubation, through intense block to complete recovery
P Schultz et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2001)
Share Paper
